Skip to main content
Clinical Trials/ACTRN12611001222932
ACTRN12611001222932
Withdrawn
未知

A randomised, single blind controlled study assessing the effect of luteal phase pipelle endometrial biopsy versus sham biopsy on live birth rate in women who are undergoing an IVF/ICSI cycle.

Phillip McChesney0 sites280 target enrollmentNovember 29, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Infertility
Sponsor
Phillip McChesney
Enrollment
280
Status
Withdrawn
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 29, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Phillip McChesney

Eligibility Criteria

Inclusion Criteria

  • A woman requiring IVF/ICSI
  • Age between 18\-39 years (up to 40th Birthday)
  • Have undergone at least 2 embryo transfers without conceiving a clinical pregnancy
  • Be ordered a starting dose of r\-FSH of 300IU or less
  • Have all previous IVF cycles resulting in 3 or more oocytes
  • BMI 35 or less
  • Both ovaries present
  • Uterine cavity without abnormality as assessed by ultrasound, hysteroscopy or hysterosalpingography

Exclusion Criteria

  • Hysteroscopy or hysterosalpingography or endometrial biopsy within the 3 months prior to study
  • Paricipating in complementary medical intervention
  • Undergoing assisted hatching
  • Current smoker
  • Previous chemotherapy or radiotherapy

Outcomes

Primary Outcomes

Not specified

Similar Trials